Results 41 to 50 of about 17,850,316 (257)

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Selection of patients and their first-degree relatives.

open access: yes, 2015
Selection of patients and their first-degree relatives.
Francis Couturaud (821892)   +3 more
core   +1 more source

Evidence of familial association between attention deficit hyperactive disorder and major depressive disorder in probands of ADHD (September 2003- march 2004)

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2005
Background&Objective: Comorbidity between ADHD (Attention Deficit Hyperactivity Disorder) and major depression has been reported from both epidemiologic and clinical studies of both children and adults.
P.Hebranei (MD)   +2 more
doaj  

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann   +8 more
wiley   +1 more source

Neurological soft signs in non-psychotic first-degree relatives of patients with schizophrenia: A systematic review and meta-analysis [PDF]

open access: yes, 2010
Background: Neurological soft signs (NSS) have been associated with the neuropsychopathology of schizophrenia, and have been proposed as candidate endophenotypes for this clinical group.
Gong, Qi-yong   +5 more
core  

Risk of Dementia in First-Degree Relatives of Patients with Alzheimer's Disease and Related Disorders [PDF]

open access: yes, 1991
First-degree relatives of patients with Alzheimer's disease (AD) are at greater risk for dementia when compared with the relatives of their healthy peers, but not when compared with the relatives of patients with Parkinson's disease.
Sano, Mary   +4 more
core   +1 more source

Evaluation of the serum fasting insulin and HOMA-IR in diabetic and FDR patients [PDF]

open access: yesJournal of Clinical and Basic Research
Background: Diabetes mellitus is an endocrine disorder. It is one of the leading causes of morbidity and mortality due to its role in the development of microvascular and macrovascular complications.
Dipalee Rahul Navale   +1 more
doaj  

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari   +5 more
wiley   +1 more source

RHD case detection among the first degree relatives according to proband status in 39 households.

open access: yes, 2021
RHD case detection among the first degree relatives according to proband status in 39 households.
Susy Kotit (11559042)   +4 more
core   +1 more source

Hyperventilation in panic disorder patients and healthy first-degree relatives

open access: yesBrazilian Journal of Medical and Biological Research, 2000
Our aim was to observe the induction of panic attacks by a hyperventilation challenge test in panic disorder patients (DSM-IV) and their healthy first-degree relatives. We randomly selected 25 panic disorder patients, 31 healthy first-degree relatives of
A.E. Nardi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy